IP Library Granted Patent US 8,278,267
Granted Patent B2
US 8,278,267 · App. 12/964,516 · Granted Oct 2, 2012

Method of modifying food preference comprising administering amylin or amylin agonist

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,278,267
App. No.
12/964,516
Granted
Oct 2, 2012
Kind
B2
Abstract

Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet and nutrition are provided. The methods provided generally involve the administration of an Amylin or an Amylin agonist to a subject in order to prevent, treat or control conditions or disorders associated with obesity, diet and nutrition.

Claims (6)

1. A method of modifying food preference of a subject desirous of modifying food preferences comprising administering to the subject an amylin or amylin agonist in an amount effective to modify the food preferences of the subject, wherein the amylin or amylin agonist is administered in an amount effective to decrease the subject's preference for high fat foods or for sweet foods.

2. The method of claim 1 , wherein the amylin or amylin agonist comprises the amino acid sequence of any one of SEQ ID NOS:3-253.

3. The method of claim 2 , wherein the amylin or amylin agonist is pramlintide (SEQ ID NO:6).

4. A method of modifying food preference of a subject desirous of modifying food preferences comprising administering to the subject an amylin or amylin agonist in an amount effective to modify the food preferences of the subject, wherein the amylin or amylin agonist is administered in an amount effective to increase the subject's preference for low fat foods.

5. The method of claim 4 , wherein the amylin or amylin agonist comprises the amino acid sequence of any one of SEQ ID NOS:3-253.

6. The method of claim 5 , wherein the amylin or amylin agonist is pramlintide (SEQ ID NO:6).

Assignments (2)
CHANGE OF NAME Recorded Aug 29, 2012
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 028868/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2011
From: WEYER, CHRISTIAN; LAUGERO, KEVIN D.; MACK, CHRISTINE M.; PARKES, DAVID G.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 025906/0740 →